Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Merck Plans $6.5 Billion Bond Offering for Stock Repurchases

May 15 (Bloomberg) -- Merck & Co., which yesterday had its unsecured debt rating cut one level by Moody’s Investors Service, plans to sell $6.5 billion of bonds in a six-part offering to fund share repurchases.

The drugmaker intends to issue $1.25 billion of 30-year notes that may pay 102 basis points more than similar-maturity Treasuries and $1.75 billion of 10-year bonds with a spread of 87 basis points, according to a person familiar with the offering who asked not to be identified, citing lack of authorization to speak publicly.

The deal also includes $1 billion portions of five-year debt yielding an extra 52 basis points, similar-maturity notes paying 36 basis points more than the London interbank offered rate, three-year securities with a spread of 32 basis points more than Treasuries and $500 million of similar-maturity floating debt paying 19 more than Libor, the person said.

A “substantial portion” of the proceeds will fund share repurchases that will reach about $7.5 billion over the next 12 months, Whitehouse Station, New Jersey-based Merck said today in a regulatory filing.

The company’s $1 billion of 2.4 percent bonds due September 2022 traded May 13 at 98.63 cents on the dollar to yield 2.57 percent, or 64.4 basis points more than similar-maturity Treasuries, according to Trace, the bond-price reporting system of the Financial Industry Regulatory Authority.

“Merck’s credit ratios will steadily weaken but remain solid as the company executes a $15 billion share repurchase program over the next several years,” Michael Levesque, an analyst at Moody’s, wrote yesterday in a report that lowered Merck’s debt that isn’t guaranteed by its Merck Sharp & Dohme unit to A2 from A1.

Shares of Merck, which has a market value of more than $140 billion, traded at $46.89 at 1:53 p.m. in New York. Libor, the rate at which banks say they can borrow in dollars from each other, was set at 0.274 percent today.

To contact the reporter on this story: Charles Mead in New York at

To contact the editor responsible for this story: Alan Goldstein at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.